GSK plc (GLAXF) has an overall financial health rating of A- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-04-06.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-04-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-04-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-20 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-03-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
